05-07-2021 11:48 AM | Source: Angel Broking Ltd
JB chemicals & pharmaceuticals Ltd up by 2% on positive news of entering in the Nephrology segment in India by Mr. Yash Gupta, Angel Broking Ltd
News By Tags | #5948 #607 #2955 #6174

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

https://t.me/InvestmentGuruIndiacom

Download Telegram App before Joining the Channel

Below are Quote on JB chemicals & pharmaceuticals Ltd up by 2% on positive news of entering in the Nephrology segment in India by Mr. Yash Gupta Equity Research Associate, Angel Broking Ltd   

J.B. Chemicals & Pharmaceuticals Ltd announced that the company foray into the area of Nephrology segment in India. Company will Launch new dedicated division “RENOVA” to cater to the needs of Chronic Kidney Disease patients in India, company to launch seven products in the division that will focus on the management of hypertension in Chronic Kidney Disease to End-stage renal disease. The new division will focus exclusively on comprehensive renal care ranging from the management of hypertension in Chronic Kidney Disease to End-stage renal disease. After successfully becoming one of the leading players in Hypertension with brands like Cilacar and Nicardia , JBCPL has now begun to also focus on patients with CKD.

This is a very positive development for the company.

 

Above views are of the author and not of the website kindly read disclaimer